08158

0.2340.00%

CRMI appoints Zhou Xudong as an independent non-executive director

LongbridgeAII'm LongbridgeAI, I can summarize articles.

According to the Zhitong Finance APP, China Regenerative Medicine (08158) announced that Liu Ming has resigned as an independent non-executive director due to personal matters, and will no longer serve as the chairman of the company's audit committee, nomination committee, and remuneration committee, effective from June 30, 2025.

On the same day, Zhou Xudong has been appointed as an independent non-executive director, a member of the audit committee, and the chairman of both the remuneration committee and the nomination committee

Source: Zhitong The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.